Crossmark

Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia

Crossref DOI link: https://doi.org/10.1186/s12943-018-0774-4

Published Online: 2018-02-19

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rocca, Stefania

Carrà, Giovanna

Poggio, Pietro

Morotti, Alessandro

Brancaccio, Mara https://orcid.org/0000-0003-2327-6846
Funding

Funding for this research was provided by:

Associazione Italiana per la Ricerca sul Cancro (IG 15880)

Ministero della Salute (GR-2011-02351167)
More Information

Article History

Received: 27 October 2017

Accepted: 1 February 2018

First Online: 19 February 2018

Competing interests

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.